Biomin Restore Plus

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention and treatment of dental sensitivity. It is formulated as a fluoride dentifrice, which aids in strengthening enamel and reducing sensitivity associated with various dental conditions.

Dosage and Administration

The recommended dosage for the product is 75 mL per 100 g of the formulation, which is equivalent to 3.5 oz. The net weight of the product is 3.35 oz (100 g).

Healthcare professionals should ensure that the product is administered according to the specified volume and weight to achieve optimal therapeutic effects. Proper measurement techniques should be employed to ensure accurate dosing.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion or misuse.

• This product is intended for adult use only and is contraindicated in individuals under the age of 18.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this product.

It is imperative that the product is not used by individuals who have a known allergy to any of its ingredients. Allergic reactions can lead to serious health complications, and therefore, a thorough review of the patient's medical history is essential prior to administration.

Patients experiencing continued tooth pain or sensitivity should be advised that these symptoms may signify an underlying dental issue that requires professional evaluation. In such cases, it is crucial to recommend that the patient consult their dentist for a comprehensive diagnosis.

Additionally, if any irritation occurs during the use of this product, it is advised to discontinue use immediately. Monitoring for adverse reactions is essential to ensure patient safety and to prevent further complications.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals who are allergic to any of its ingredients. Allergic reactions may pose serious health risks and should be avoided.

In clinical practice, it is important to monitor for continued tooth pain or sensitivity, as these symptoms may indicate an underlying dental issue that requires professional evaluation. Should these symptoms persist, patients are advised to consult their dentist for further diagnosis and appropriate management. Additionally, if any irritation occurs during the use of this product, it is recommended to discontinue use immediately to prevent further complications.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Biomin Restore Plus (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not have access to this medication, as it is intended for adult use only. It is crucial to keep this product out of reach of children to prevent accidental ingestion or misuse.

Geriatric Use

Elderly patients are not the intended population for this medication, as it is indicated for adult use only. Therefore, the safety and efficacy of this medication in geriatric patients have not been established. Healthcare providers should exercise caution when considering the use of this medication in elderly patients, as the lack of specific data may necessitate careful monitoring and evaluation of potential risks versus benefits.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the individual patient's liver status when prescribing this medication.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as required.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details are available in the extracted data. As such, there are no additional adverse events or rare case reports to summarize.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize that this medication is intended for adult use only, and patients should not share it with others.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures not exceeding 30°C to maintain its integrity and efficacy.

Healthcare professionals are advised to inspect the packaging prior to use; the product should not be utilized if the package is found to be damaged, as this may compromise the quality and safety of the product. Proper handling and storage conditions are crucial to ensure optimal performance.

Additional Clinical Information

Patients should brush twice daily for 2 minutes, ideally in the morning and at night. During brushing, they should swirl the foamy dentifrice around their mouth for 30 seconds before spitting it out, and it is important not to swallow the product or rinse the mouth with water afterward.

Clinicians should advise patients that continued tooth pain or sensitivity may indicate an underlying issue requiring professional evaluation. If symptoms persist, patients are encouraged to consult their dentist. Additionally, if any irritation occurs, the use of the product should be discontinued.

Drug Information (PDF)

This file contains official product information for Biomin Restore Plus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)